← FDA Drug Approvals (Drugs@FDA)
CLOZAPINE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: AUROBINDO PHARMA · Approved 2024-12-12
Drug application
- FDA Application #
ANDA212923- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- CLOZAPINE
- Generic name
- CLOZAPINE
- Active ingredients
- CLOZAPINE
- Dosage form
- TABLET, ORALLY DISINTEGRATING
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- AUROBINDO PHARMA
- Manufacturer
- Aurobindo Pharma Limited
- First approval
- 2024-12-12
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown